ApoCell Expands Immuno-Oncology Biomarker Services to Develop Liquid Biopsy and Tumor Tissue Tests using the PerkinElmer Vectra Polaris Platform

HOUSTON, Sept. 12, 2018 /PRNewswire/ -- ApoCell, Inc., a pioneer in customized biomarker solutions, today announced the offer of services using the PerkinElmer Vectra® Polaris™ System Automated Quanti...

Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies

Boehringer Ingelheim exercises its option to acquire all shares of oncolytic virus company ViraTherapeutics ViraTherapeutics will operate in Innsbruck, Austria as a distinct unit of Boehringer Ingelhe...